Share Name Share Symbol Market Type Share ISIN Share Description
Akers Biosciences, Inc LSE:AKR London Ordinary Share COM SHS NPV
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 19.50p 0.00p 0.00p - - - 0 05:30:10
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 2.9 -4.3 -45.2 - 17.73

Akers Biosciences Share Discussion Threads

Showing 3851 to 3873 of 3875 messages
Chat Pages: 155  154  153  152  151  150  149  148  147  146  145  144  Older
DateSubjectAuthorDiscuss
18/7/2018
14:37
Akers Biosciences (AKR) News Out Just Now http://crweworld.com/article/news-provided-by-globenewswire/740118/akers-biosciences-signs-a-further-independent-sales-representative-organization-for-heparin-pf4-rapid-test-covering-additional-12-states
danieldanj
18/7/2018
11:55
As feared, Gormally seems to have as much of a clue re PIFA Heparin / it's efficacy / selling it / etc as Walt; this is the fella who, following GNYHA having informally given the go ahead for the device to be sold in Puerto Rico, said "release the hounds". A very unusual thing for a grown man - nevermind a CEO - to say in my opinion. This is about the 15th new strategy to try to sell their 'flagship' device.... "....The Company is taking steps to improve its market presence for PIFA Heparin PF/4 Rapid Assay products including through the use of specialized Independent Sales Representatives (ISRs) and through a program to educate the marketplace through the preparation and publication of additional clinical studies"
mcmather
14/7/2018
09:55
Akers Biosciences (AKR) Earnings-Reaction to Keep an Eye http://crweworld.com/article/news-provided-by-globenewswire/735780/akers-biosciences-announces-q1-2018-earnings
danieldanj
13/7/2018
23:36
Akers Biosciences (AKR) News Out Just Now http://crweworld.com/article/news-provided-by-globenewswire/735768/akers-biosciences-files-restated-previously-issued-financial-statements-for-2017
danieldanj
30/6/2018
18:20
Still time to look at Akers Biosciences (AKR) - Upcoming Key Date http://crweworld.com/article/news-provided-by-globenewswire/720949/akers-biosciences-requests-temporary-suspension-of-trading-on-london-stock-exchange
danieldanj
29/6/2018
15:02
All you guys that ramped this POS Should say you are sorry
buywell3
20/6/2018
13:00
Is Walt getting ready for a knock at the door? "The Company is currently unable to quantify the level of recognisable revenues for the periods covered in these Reports, however it is expected that revenues will be lower than previously reported and losses for these periods will be greater".
mcmather
17/6/2018
18:20
How come there is a rns (see below) on Nasdaq but not yet on here? ---------- "...The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Akers Biosciences, Inc. ("Akers" or the "Company") (NASDAQ: AKER) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. On May 21, 2018, Akers announced that it was unable to file its Form 10-Q quarterly report with the SEC for the period ending March 31, 2018. The Company added that its internal review has expanded to include the “characterization of certain revenue recognition items . . . now includes certain transactions in previous quarters.” On May 22, 2018, shares of Akers fell more than 8% based on this news. On May 29, 2018, Akers announced that “Raymond F. Akers Jr., Ph.D. has resigned as a director of the Company with immediate effect.” Akers shares fell 33% the same day based on this announcement. On June 1, the Company released a letter to the SEC from Dr. Raymond Akers stating that he “resigned from the Board of Directors due to significant differences regarding the policies and practices of the Board of Directors, accounting and business practices of Management, and new Counsel.” If you are a shareholder who suffered a loss, click here to participate....."
algernon2
06/6/2018
08:42
Hmmmm: "On behalf of Ray Akers, we believe the language of the 8K regarding Ray is false, totally misleading, and such that will cause Ray to have to take corrective action. Ray is a whistleblower; the only reason there is an investigation regarding revenue recognition is because Ray refused to approve the 10K for 2017 and demanded an investigation. To say he is being “uncooperative” is utterly disingenuious and will not be tolerated".
mcmather
31/5/2018
21:36
Maybe at some point in time we may be invited to take part in some American "class action" depending upon what has been going on exactly.Thanks mcmather.
algernon2
31/5/2018
19:01
Algernon, buywell only posted here to reference another bio share - sbs possibly? - in the hope of gaining some interest with that. That's likely why you don't remember him / his posts. Re norbus; I think there was a month or so where he was invested but he definitely didn't "champion" akr. The threads on akr are easy enough to check. Each product had some potential at one time or another but walt 'knew' what he was doing when, cough, agreements would end in disputes. There's been some very unusual 'deals' here down the years and it will be interesting to see whether the authorities show an interest in walt's activities here.
mcmather
31/5/2018
16:27
Thanks to Buywell as well then. One would have done well to listen.
algernon2
31/5/2018
13:32
Norbus championed this share for quite a time , and bought some too buywell3 on the other hand has always called it what it was ... using the chart to guide him and not a coin toss
buywell3
29/5/2018
22:19
I'm guessing either Walt has been a naughty boy or the Chlamydia device actually works and someone might be trying to get their hands on it on the cheap. Past form cautions against Walt producing any magic save for an ability to make funds raised quickly disappear, so?
mcmather
29/5/2018
17:44
When the dust has settled a bit can someone tell me what has been going on. Not one of my better investments.I should have listened to Norbus. Buy Hey Ho "..we still have Paris" and hopefully Oxb and Summ.
algernon2
29/5/2018
15:22
Can't see walt voluntarily leaving; hopefully this will all be investigated accordingly.
mcmather
29/5/2018
12:50
Akers Biosciences (AKR) has decided to withdraw its initial U.S. FDA 510(k) application for PIFA Chlamydia Rapid Assay to re-evaluate its options. Here is the link http://crweworld.com/article/news-provided-by-globenewswire/309108/akers-biosciences-withdraws-fda-510k-submission-for-pifa-chlamydia-rapid-assay-pending-further-evaluation
danieldanj
29/5/2018
10:51
He has conned the world and his wife for $millions. He must be made to cough out
norbus
29/5/2018
10:50
Could be go to jail,
norbus
29/5/2018
10:09
Or down the toilet
norbus
29/5/2018
09:51
Up the kazoo . You have to admire his chutzpah. Only man I know who made real money out of AKR. Looking a basket case
norbus
29/5/2018
07:13
Where's Wally?
mcmather
25/5/2018
23:11
Akers Biosciences (AIM:AKR) (Nasdaq:AKER) has received a notice from Nasdaq’s Listing Qualifications Department. Here’s the link http://crweworld.com/article/news-provided-by-globenewswire/308203/akers-biosciences-receives-notice-of-delinquent-form-10-q-filing-from-nasdaq
danieldanj
Chat Pages: 155  154  153  152  151  150  149  148  147  146  145  144  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:43 V: D:20180721 11:41:26